The inositol 5-phosphatase SHIP (SHIP-1) is a negative regulator of signal transduction in hematopoietic cells and targeted disruption of SHIP in mice leads to a myeloproliferative disorder. We analyzed the effects of SHIP on the human leukemia cell line Jurkat in which expression of endogenous SHIP protein is not detectable. Restoration of SHIP expression in Jurkat cells with an inducible expression system caused a 69% reduction of phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P 3 ) and a 65% reduction of Akt kinase activity, which was associated with reduced phosphorylation of glycogen synthase kinase 3b (GSK-3b) (Ser-9) without changing the phosphorylation of Bad (Ser-136), FKHR (Ser-256) or MAPK (Thr-202/Tyr-204). SHIP-expressing Jurkat cells showed an increased transit time through the G1 phase of the cell cycle, but SHIP did not cause a complete cell cycle arrest or apoptosis. Extension of the G1 phase was associated with an increased stability of the cell cycle inhibitor p27
Introduction
Constitutive activation of signaling pathways involved in the stimulation of proliferation or inhibition of apoptosis are considered important events during tumorigenesis. Several lines of evidence indicate that the inappropriate activation of phosphatidylinositol 3-kinase (PI3K) can contribute to the transforming process (for a review, see Cantley, 1 Cantley and Neel 2 and Cheng et al 3 ) . These include the identification of the viral oncogene v-p3k as a homologous gene of PI3K, 4 the association of PI3K with oncogene products like polyoma middle T antigen or v-Src [5] [6] [7] and the characterization of mutated forms of the p85 subunit of PI3K. 8 Additional evidence for the involvement of PI3K-generated phospholipids in the process of transformation came from the identification of the phosphatase PTEN as a tumor suppressor gene. 9 PTEN counteracts the effects of PI3K by dephosphorylating 3 0 -phosphorylated phosphatidylinositolphosphates and the enzymatic activity of PTEN is necessary for its function as a tumor suppressor gene.
10 PI3K-generated phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P 3 ) can bind Akt (also known as protein kinase B (PKB)), which is subsequently activated by sequential phosphorylation on threonine 308 and serine 473. 11 Akt has been identified as the viral oncogene v-akt and activation of Akt is one of the crucial steps in transferring the oncogenic signal initiated from a constitutively activated PI3K. 12 Involvement of PI3K/Akt signaling in leukemogenesis has been demonstrated for the process of transformation of hematopoietic cells by BCR/ ABL 13 and a mutated form of the p85 subunit of PI3K has been identified in a human hematopoietic cell line. 14 Owing to the large number and variety of human tumors associated with activated PI3K/Akt signaling, this pathway seems to be a promising target for cancer therapy. 3 An important player in the regulation of the PI3K/Akt signaling pathway in hematopoietic cells is the SH2 domain-containing inositol polyphosphate 5-phosphatase SHIP (SHIP-1). 15, 16 SHIP is expressed in all hematopoietic cells analyzed so far, including CD34 þ cells derived from human bone marrow. [17] [18] [19] Stimulation of mast cells derived from SHIP À/À mice with granulocytemacrophage colony stimulating factor (GM-CSF) or interleukin-3 (IL-3) results in an increased and prolonged PI3K-dependent PtdIns(3,4,5)P 3 accumulation and Akt activation in these cells. 20 In addition, targeted disruption of SHIP in mice leads to a myeloproliferative disorder due to an increased sensitivity of the hematopoietic cells for several cytokines including GM-CSF and IL-3. 20, 21 Additional data suggest that SHIP may have a tumorsuppressor-like function in BCR/ABL-mediated transformation of hematopoietic cells and in human chronic myeloid leukemia. 22, 23 Recently, a mutation in the second consensus motif of the phosphatase domain of SHIP has been detected in a patient with acute myeloid leukemia. 24 These data indicate that SHIP is a negative regulator of PI3K/Akt signaling in hematopoietic cells and suggest a possible function of SHIP in the pathogenesis of human leukemia.
In the present report, we provide evidence that restoration of SHIP activity in the human leukemia cell line Jurkat, which has lost expression of endogenous SHIP, leads to an inhibition of the constitutively activated PI3K/Akt/glycogen synthase kinase 3b (GSK-3b) signaling pathway and to a reduced proliferation of these cells. By using an inducible retroviral expression system, we observed an SHIP-mediated increase in the transit time through the G1 phase of the cell cycle, which was associated with stabilization of the cell cycle inhibitor p27 Kip1 and reduced phosphorylation of the retinoblastoma (Rb) protein.
Materials and methods

Cells
Jurkat is a human T-cell line which had been established from a patient with acute lymphoblastic leukemia. 25 Jurkat Tet-On cells carrying the reverse transactivator (BD Clontech, Heidelberg, Germany) were cultured in RPMI 1640 Glutamax medium (Invitrogen, Karlsruhe, Germany) supplemented with 10% (vol/ vol) fetal calf serum (FCS) and 1 mM sodium pyruvate. The factor-independent TF-1 mutant I33-5 has been established from the GM-CSF-dependent human erythroleukemia cell line TF-1 26 after selection for growth factor independence in medium not supplemented with GM-CSF. 27 Cloning of SHIP Isolation of RNA and Northern blot analysis were performed as described previously. 28 A human SHIP cDNA was cloned from a factor-independent TF-1 mutant (I33-5) by RT-PCR using the Superscript s reverse transcriptase (Invitrogen, Karlsruhe, Germany) for cDNA synthesis and the Pwo proof-reading polymerase (Roche Diagnostics, Mannheim, Germany) for amplification. The following forward primers (FP) and reverse primers (RP) with additional restriction enzyme sites for subcloning were used according to the published cDNA sequence of human SHIP (Genebank U57650). 29 For amplification of the 5 0 -half of SHIP, the primers FP273 (ccccggatccctct ctttctctctctctctcttgc) and RP4415 5 0 -tattgtcgacatctatatctccaccctcaaatcgg-3 0 were used followed by a nested PCR with FP507 (gaggaagcttcccaccatggtcccctgctggaacc) and RP3124 (gattgcgg ccgctccgtcttcacaaagtcatagagc). The 3 0 -half was amplified with FP2805 (gagtgaattcggagaaaatgaagaaggaagtgagg) and RP4682 (aggcaagctttaccctaaacaagctacccagactc). The 5 0 -and 3 0 -halfs of SHIP were ligated by using the NcoI site at 3026 and subcloned in pGEM-3Z. Sequence analysis of the open reading frame revealed five differences in comparison to the published cDNA of human SHIP 29 including three silent mutations and one mutation leading to an amino-acid exchange (H1168Y), which was reversed to wild type by site-directed mutagenesis. Three additional base pairs (gta) were detected at position 349-351 of the open reading frame resulting in an additional amino acid (valine) between residues threonine 116 and glutamic acid 117. This additional amino acid has also been detected in the human SHIP cDNA cloned in the laboratory of L Rohrschneider (U84400). 17 The tetracycline inducible expression system
The human SHIP cDNA was subcloned in the BamHI site of the retroviral expression vector pLTR-Tet-SV-HPH. This tetracycline inducible coexpression vector was constructed by cloning an SV40 promoter and a hygromycin-resistance gene in the vector pLTR-tet, which has a tetracycline response element (TRE) in the 3'-LTR (kindly provided by C Stocking, Heinrich-Pette-Institut, Hamburg, Germany). Amphotropic retroviruses were generated by calcium phosphate transfection in the Phoenix-Ampho packaging cell line (kindly provided by G Nolan, Stanford University, USA) cultivated in DMEM medium supplemented with 25 mM chloroquine. Virus titer was increased by cotransfection of a plasmid encoding the vesicular stomatitis virus G protein (pHCMV-vesicular stomatitis virus G protein (VSV-G)) and a plasmid encoding the retroviral gag and pol proteins (pSVgp) (kindly provided by D von Laer, Heinrich-PetteInstitute, Hamburg, Germany). Virus supernatants were collected 48 h after transfection, filtered and stored at À801C until used. Infection of Jurkat Tet-On cells was performed by infecting the cells three times over a period of 3 days with the pseudotyped viruses. A mass culture of infected cells was selected in hygromycin and individual clones were obtained by limiting dilution. Expression of SHIP in individual clones was induced by addition of doxycycline (Dox) (1000 ng/ml) to the medium for 48 h and analyzed by anti-SHIP immunoblotting.
Analysis of cell cycle, cell division and apoptosis
Cell cycle analysis was performed as described previously. 30 Cell division was analyzed by labeling cells with carboxyfluorescein diacetate succinimidyl ester (CFDA SE) (Molecular Probes, Leiden, Netherlands). Cells were incubated for 15 min with 10 mM CFDA SE at 371C. CFDA SE diffuses in the cells and is nonfluorescent until the acetate groups are cleaved by intracellular esterases to yield the highly fluorescent carboxyfluorescein succinimidyl ester (CFSE). CFSE reacts with intracellular amines to form fluorescent conjugates that are retained in the cell. An aliquot of the CFSE-labeled cells was treated with 0.1 mg/ml colcemid to block cell division. After 48 h cells were fixed in 70% methanol and analyzed by flow cytometry.
Apoptotic cell death was analyzed by three methods: (i) cells were incubated with Annexin V-FITC (Oncogene, Boston, MA, USA) and 0.6 mg/ml propidium iodide followed by flow cytometry analysis, (ii) the appearance of apoptotic bodies was analyzed under a microscope after staining the cells with DAPI (Sigma-Aldrich, Taufkirchen, Germany) and (iii) cleavage of poly(ADP-ribose)-polymerase (PARP) was analyzed by Western blotting with a PARP-specific antibody (Cell Signaling Technology, Beverly, MA, USA).
Western blotting, immunoprecipitation and in vitro kinase assays Cells were lysed in Nonidet s P40 (NP 40)-containing lysis buffer as described. 31 Cell lysates were analyzed by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) and Western blot analysis as described. 31 For immunoblotting, antibodies were used directed against SHIP (P1C1 and V19), Akt (C-20), MAPK (K-23), phosphotyrosine (PY99), p27 Kip1 (sc-1641) (Santa Cruz Biotechnology, Heidelberg, Germany), PTEN, retinoblastoma protein (pRB), phosphoAkt(Thr308), phospho-Akt(Ser473), phospho-MAPK(Thr202/ Tyr204), phospho-Rb(Ser780), phospho-FKHR(Ser256), phospho-BAD(Ser136), phospho-GSK-3b(Ser9) (Cell Signaling Technology, Beverly, MA, USA), cyclin D3 (C13) (Oncogene, Boston, MA, USA), cyclin D1 (BD Pharmingen, San Diego, CA, USA). Antisera against SHIP were produced by immunization of rabbits with a synthetic peptide of the human SHIP protein consisting of the first NPXY-motif, that is, (NPNYMGVG PFGPPMPLHV) and purified by affinity chromatography.
Immunoprecipitation of proteins from total cell lysates was performed as described previously. 31 To analyze Akt activity, we used a fusion protein of glutathione-S-transferase (GST) and glycogen synthase kinase-3b (GSK-3b) as exogenous substrate. Akt was immunoprecipitated from 1 mg total cell lysate with 4 mg anti-Akt antibody (sc-1618, Santa Cruz Biotechnology, Heidelberg, Germany) and washed three times with Nonidet s P40 (NP40) lysis buffer and two times with kinase buffer (25 mM Tris-HCl pH 7.5, 10 mM MgCl2, 5 mM b-glycerophosphate, 2 mM dithiothreitol (DTT), 0.1 mM sodium orthovanadate). The kinase reaction was performed for 30 min at 301C in 40 ml kinase buffer with 200 mM ATP and 1 mg GST-GSK-3b fusion protein (Cell Signaling Technology, Beverly, MA, USA). The reaction Effects of SHIP on signal transduction and proliferation S Horn et al was stopped by the addition of gel loading buffer and DTT (100 mM). The activity of Akt was evaluated by analyzing the phosphorylation of the GST-GSK-3b fusion protein with an antibody specific for Ser-9 of GSK-3b. Chemiluminescent signals of the phosphorylation of GSK-3b (Ser-9) and of immunoprecipitated Akt were measured in a Multi-Imager (BioRad, Munich, Germany). The relative activity of Akt was obtained by calculating the ratio of GSK-3b phosphorylation at Ser-9 and the amounts of Akt immunoprecipitated in each assay.
Phosphoinositide analysis
Extraction and mass analysis of phosphoinositides were performed from deacylated phosphoinositides by metal dye detection high-performance liquid chromatography (MDD-HPLC) on a SMART HPLC system (Amersham Pharmacia Biotech, Freiburg, Germany) as described. 32 Shortly, glycerophospho-inositol phosphates (GroPInsP's) were separated on a Mini Q ammonium anion exchanger column with 3 mM nominal particle size (Amersham Pharmacia Biotech, Freiburg, Germany). Elution was performed with a gradient of HCl (0.25-250 mM) containing 15 mM YCl 3 . Postcolumn derivatization reagent contained 1.6 M triethanolamine pH 9.2 and 300 mM 4-(2-pyridylazo)resorcinol. The amounts of GroPIns(3,4,5)P 3 were measured by using deacylated PtdIns(3,4,5)P 3 as standard (Calbiochem, Merck Biosciences, Schwalbach, Germany).
Results
Constitutive activation of Akt in Jurkat cells is downregulated by re-expression of SHIP
SHIP is a negative regulator of several signaling processes in hematopoietic cells and SHIP-deficient mice develop a myeloproliferative disease. These results offer the possibility that inactivation of SHIP may occur in human hematopoietic cells leading to unregulated growth and survival which may contribute to leukemogenesis. The absence of SHIP proteins has been reported in the human T-cell line Jurkat which has been derived from a patient with T-cell acute lymphoblastic leukemia. 33, 25 Indeed, immunoblot analysis confirmed the absence of detectable SHIP proteins in Jurkat cells ( Figure 1a , lane 1). This result was obtained with anti-SHIP antibodies directed against the first NPXY motif of SHIP (S-5) and was confirmed with anti-SHIP antibodies directed against a Cterminal region of SHIP (P1C1) and an N-terminal region of SHIP (V19) (data not shown). Proteolytic cleavage of SHIP in hematopoietic cell lines and in primary leukemia samples can occur during the preparation of protein extracts under nondenaturing conditions resulting in an artificial cleavage of SHIP proteins. 19 The analysis of SHIP proteins in Jurkat cell extracts prepared under denaturing conditions, that is, in boiling SDS buffer, which avoids any artificial cleavage of SHIP, confirmed the absence of SHIP proteins in Jurkat cells (data not shown). Northern blot analysis of Jurkat cells revealed a very weak detection of a 5 kb SHIP mRNA after long exposure only, indicating that ship is weakly expressed at the RNA level (data not shown). Therefore, the possibility that SHIP proteins are present at very low levels in Jurkat cells under the detection limit of the immunoblot analysis cannot be excluded.
Stimulation of hematopoietic cells from SHIP-knockout mice revealed an increased and prolonged PI3K-dependent PtdIns(3,4,5)P 3 accumulation and Akt activation implicating SHIP in the regulation of PI3K/Akt signaling. 20 Akt becomes fully activated by sequential phosphorylation at residues threonine 308 and serine 473. By using phospho-specific antibodies directed against Akt (phospho-Akt), a strong constitutive phosphorylation of Akt at serine 473 and threonine 308 was To further substantiate a causal relationship between SHIP expression and the loss of Akt phosphorylation in Jurkat cells, a dose-response experiment was performed. Jurkat Tet-On cells were incubated for 48 h with increasing amounts of Dox. There was an inverse correlation between SHIP expression and Akt phosphorylation at serine residue 473 and threonine 308 in a concentration-dependent manner ( Figure 1b) . A time course experiment performed with 1000 ng/ml Dox revealed a maximal effect of SHIP expression and dephosphorylation of Akt 48 h after induction of SHIP expression (data not shown). In addition, Akt kinase activity was measured in an in vitro kinase assay by using a fusion protein consisting of glutathione-S-transferase (GST) and GSK-3b as exogenous substrate. Induction of SHIP expression in the Jurkat-SHIP clone #51 resulted in a decrease of Akt kinase activity ( Figure 1c) . Quantification of the phosphorylation of GSK3b relative to the amount of immunoprecipitated Akt revealed a 65% reduction of the activity of Akt after induction of SHIP. These data indicate that the induced expression of SHIP downregulates phosphorylation and activity of Akt and that this effect can be titrated by the amount of Dox added to the culture medium.
Reduced levels of PtdIns(3,4,5)P 3 after restoration of SHIP activity
The detection of phosphorylated Akt in Jurkat cells suggested that PI3K is constitutively activated in these cells. The levels of PtdIns(3,4,5)P 3 in Jurkat cells were analyzed by metal dye detection HPLC. The amounts of PtdIns(3,4,5)P 3 present in Jurkat-SHIP #51 before and after induction of SHIP expression were measured by using various amounts of deacylated PtdIns(3,4,5)P 3 ranging from 9.6 to 153. 
SHIP mediates a differential downregulation of constitutively phosphorylated Akt substrates
Expression of SHIP in Jurkat cells leads to reduced steady-state level of PtdIns(3,4,5)P 3 and reduced phosphorylation and activity of Akt. Akt phosphorylates several substrates at distinct sites like GSK-3b on serine 9, Bad on serine 136 and FKHR on serine 256. [34] [35] [36] By using phospho-specific antibodies, the phosphorylation state of these residues was analyzed in three Jurkat clones before and after induction of SHIP expression. As shown in Figure 3 , GSK-3b, Bad and FKHR are constitutively phosphorylated at serine residues 9, 136 and 256, respectively, in the parental Jurkat cells (lane 1), in Jurkat-Tet-On cells (lane 2), in a vector clone (lane 3) and in three Jurkat-SHIP clones (#29, #39, #51) before induction of SHIP expression (lanes 5, 7 and 9). After the induction of SHIP expression, phosphorylation of GSK-3b at serine 9 was reduced in the three clones analyzed and this reduction of GSK-3b phosphorylation correlated inversely with the level of induced SHIP expression (Figure 3,  lanes 6, 8 and 10 ). In contrast, the levels of phosphorylation of Bad at serine residue 136 and FKHR at serine residue 256 were not changed after expression of SHIP (lanes 5 to 10). These data indicate that SHIP mediates a differential downregulation of constitutively phosphorylated Akt substrates associated with proliferation, that is, GSK-3b, but not apoptosis, that is, Bad and FKHR in these cells.
Reduced proliferation of Jurkat cells without cell death after expression of SHIP
To determine whether the re-expression of SHIP and the downregulation of Akt activity in Jurkat cells has a biological effect, proliferation and cell death including apoptosis were Treatment of the vector clone (vector #6) with Dox had no effect on the proliferation of these cells (Figure 4a ). The reduced cell number after the expression of SHIP may be due to apoptotic or necrotic cell death. Annexin-V-FITC and propidium iodide were added to Jurkat-SHIP clones #39 and #51 and to the vector control clone #6 which had been treated without or with Dox. Flow cytometry analysis of these cells did not reveal an increase of apoptotic or necrotic cell death in SHIP-expressing cells as compared to the vector clone (data not shown). Further analysis of apoptotic processes in these cells did not reveal an increase of cells with apoptotic bodies or the appearance of the cleaved form of PARP (data not shown). From these data it was concluded that SHIP-expressing cells do not die by apoptosis or necrosis, suggesting that the reduced cell number is due to a slower proliferation which should be associated with changes in cell cycle distribution. Indeed, cell cycle analysis of two Jurkat-SHIP clones (SHIP #39 and #51) showed an increased percentage of cells in G0/G1 phase and a concomitant reduction of the percentage of cells in S phase and G2/M phase after induction of SHIP expression (Figure 4b) . A time course experiment performed over 5 days showed that this effect on cell cycle distribution increased with time (data not shown). To provide further evidence for a direct role of SHIP in the increased percentage of G0/G1 cells, the expression level of SHIP in distinct cell populations was correlated with their distribution in the cell cycle. This was performed by staining of the cells with a monoclonal anti-SHIP antibody (P1C1) followed by cell cycle analysis. Gating of cell populations, which express low or high levels of SHIP followed by cell cycle analysis, revealed a correlation between the amount of SHIP expression and the increased percentage of cells in G0/G1 (data not shown).
The observed increase in the percentage of Jurkat cells in G0/ G1 phase after expression of SHIP could be either due to an accumulation of cells in G1 or an increased number of cells Reduced levels of PtdIns(3,4,5)P 3 in Jurkat cells after expression of SHIP. (a) Sister cultures of Jurkat SHIP #51 cells were grown for 3 days in the absence (ÀDox) or presence ( þ Dox) of 1 mg/ ml Dox. For each analysis, the phosphoinositides were extracted from 1 Â 10 8 cells. After deacylation, the glycerophosphoinositol phosphates (GroPInsP's) were analyzed by metal dye detection (MDD)-HPLC as described in Materials and methods. Purified phosphoinositides were deacylated and used as standards, that is, GroPIns(4,5)P 2 and GroPIns(3,4,5)P 3 . In (a), the chromatograms of extracts from Jurkat SHIP #51 cells before (ÀDox) or after ( þ Dox) induction of SHIP expression were superimposed on the elution profile of a mixture of 190 pmol GroPIns(4,5)P 2 and 30 pmol GroPIns(3,4,5)P 3 (standard). The arrows with a star (n) indicate peaks which do not represent glycerophosphoinositols. (b) The amounts of GroPIns(3,4,5)P 3 in Jurkat SHIP #51 cells before induction (ÀDox) or after induction ( þ Dox) of SHIP expression were determined by MDD-HPLC with purified GroPIns(3,4,5)P 3 as standard. A two-tailed students t-test was performed for statistical analysis of the amounts of GroPIns(3,4,5)P 3 before and after SHIP expression. The P-value of three independent experiments was P ¼ 0.001 (nn).
Figure 3
SHIP mediates a differential downregulation of constitutively phosphorylated Akt substrates. Vector-infected Jurkat Tet-On cells (vector #6) (lanes 3 and 4) and three Jurkat SHIP clones (#29, #39, #51) (lanes 5 to 10) were either left untreated (lanes 3, 5, 7, 9) or were treated with 1000 ng/ml doxycycline (Dox) for 48 h (lanes 4, 6, 8 and 10). In addition, untreated parental Jurkat cells (lane 1) and Jurkat Tet-On cells (lane 2) were also analyzed. Cell extracts were prepared and analyzed by immunoblotting for expression of SHIP, phosphorylation of gylcogen synthase kinase 3b (GSK-3b) at serine residue 9 (phospho-GSK3b S9), phosphorylation of BAD at serine residue 136 (phospho-BAD S136), phosphorylation of FKHR at serine residue 256 (phospho-FKHR S256) and expression of MAP-kinases Erk1/Erk2 (MAPK).
Effects of SHIP on signal transduction and proliferation S Horn et al leaving the cell cycle and become quiescent (G0). To discriminate between these possibilities, the cells were stained with an antibody against the proliferation marker Ki-67, which is expressed during the cell cycle including G1, but not in quiescent cells, that is, G0. 37 After the expression of SHIP, an increase in the percentage of Ki-67 negative (G0) cells was not observed (data not shown). These results indicate that the increase in the percentage of G0/G1 cells after the induction of SHIP expression is due to an accumulating number of cells in G1 and not to an increased number of quiescent cells in G0.
Stathmokinetic analysis reveals an increased transit time of SHIP-expressing Jurkat cells through the G1 phase of the cell cycle without a complete cell cycle arrest
Increased numbers of cells in the G1 phase of the cell cycle after induced expression of SHIP may be due to an increased transit time through the G1 phase of the cell cycle or a complete cell cycle arrest in G1. To discriminate between these possibilities, Jurkat-SHIP #51 cells were labeled with the fluorescence dye CFSE. If cells divide they distribute the dye to both daughter cells each receiving half of the dye. Cells that are completely arrested in the cell cycle can be identified as nondividing cells because they do not show a reduction of the fluorescence signal. As a control for cells arrested in the cell cycle, colcemide-treated cells were used. All Jurkat-SHIP #51 cells either without or with induced SHIP expression showed a reduced fluorescence signal 2 days after the CFDA labeling, thereby excluding a complete cell cycle arrest caused by SHIP (Figure 5a ). SHIP-expressing Jurkat cells showed a higher fluorescence labeling than Jurkat cells which do not express SHIP, indicating a difference in the number of cell divisions. The number of cell divisions can be followed by the decrease in fluorescence intensity (FI) which is less by half after each division. Quantification of the fluorescence signals revealed that Jurkat cells which do not express SHIP had performed almost three cell divisions in 3 days (1672% remaining fluorescence intensity), whereas SHIPexpressing Jurkat cells had performed nearly two divisions in 3 days only (2773% remaining fluorescence intensity).
Next, the transit time through the G1 phase of the cell cycle was determined by stathmokinetic analysis. Sister cultures of Jurkat-SHIP #51 cells were treated for 5 days without or with 1 mg/ml Dox. The cells were then either directly fixed (t 0 ) or further cultured in the presence of 0.1 mg/ml colcemide or with buffer as control. A fraction of the cells was taken each hour from the cultures for a period of 16 h and cell cycle analysis was performed for each time point. As shown in Figure 5b , SHIPexpressing Jurkat cells needed 9.5 h until 50% of the G1 cells left the G1 phase of the cell cycle, whereas cells not expressing SHIP needed 6 h only. These data indicate that the reduced proliferation of Jurkat cells after the induced expression of SHIP is due to an increased transit time through the G1 phase of the cell cycle.
Induced expression of SHIP affects the G1 cell cycle regulators Rb and Kip1
Induced expression of SHIP in Jurkat cells caused an increased transit time through the G1 phase of the cell cycle. To identify the proteins involved in this SHIP-mediated regulation, the activation state of G1 cell cycle regulators was analyzed. Cyclins regulate cell cycle progression by binding to cyclindependent kinases (CDK). Sequential phosphorylation of the Rb protein by cyclin D-CDK4/6 and cyclin E-CDK2 inactivates the growth-inhibitory function of Rb during the G1 phase. 38, 39 The phosphorylation of Rb at serine residue 780, which is phosphorylated by CDK4, 40 was analyzed in Jurkat-SHIP cells by immunoblotting with phospho-specific antibodies for serine residue 780 of Rb. As shown in Figure 6a , phosphorylation of Rb at serine residue 780 was reduced in two Jurkat-SHIP clones (#39 and #51) but not in a control clone (vector #6) after induced expression of SHIP. Dephosphorylation of Rb at Serine 780 was inversely correlated to the concentration of Dox added to the medium and to the amount of induced SHIP expression (Figure 6a, lanes 7-9) .
The activity of the cyclin-CDK complexes is further regulated by CDK inhibitors. A PI3K/Akt-dependent downregulation of the stability of the CDK inhibitor p27
Kip1 has been recently demonstrated in hematopoietic cells after the induced expression of BCR/ABL. 41 To analyze whether the SHIP-mediated reduction of PI3K/Akt signaling has an effect on the stability of p27 Kip1 , sister cultures of Jurkat cells that either express SHIP ( þ Dox) or do not express SHIP (ÀDox) were treated with cycloheximide to inhibit the synthesis of new proteins. The stability of p27
Kip1 was analyzed after treatment with cycloheximide for 8 and 13 h by anti-Kip1 immunoblotting. As shown in Figure 6b , the induction of SHIP expression in Jurkat cells caused an increased stability of p27 Kip1 . At the same time, a 24 kDa protein becomes detectable with the anti-Kip1 monoclonal antibody (Figure 6b ). This 24 kDa protein may be Effects of SHIP on signal transduction and proliferation S Horn et al identical to the N-terminal truncated form of p27 Kip1 which is generated after removal of the cyclin-binding domain at the Nterminus of p27 Kip1 . 42 The increased stability of p27 Kip1 after induction of SHIP expression resulted in an 1.8-and 1.6-fold increase of the steady-state levels of p27
Kip1 in the Jurkat-SHIP clones #39 and #51, respectively (Figure 6c ). These results indicate that the expression of SHIP affects two important cell cycle regulators of the G1 phase of the cell cycle, that is, Kip1 and Rb. The increased expression of Kip1 and the reduced phosphorylation of Rb may be involved in the increased transit time through the G1 phase of the cell cycle observed after the expression of SHIP in Jurkat cells.
Discussion
Expression of SHIP-1 has been detected in all hematopoietic cell lineages analyzed including immature and mature T lymphocytes. 17, 18 However, the human T-cell leukemia cell line Jurkat does not express detectable amounts of SHIP proteins. 33 By using an inducible expression system (Tet-On), expression and activity of SHIP was restored in Jurkat cells and the biochemical and biological effects were analyzed. In this study, evidence is provided that restoration of SHIP activity in Jurkat cells causes a reduced proliferation of these cells without detectable cell death by apoptosis. Reduced proliferation of Jurkat cells after the induced expression of SHIP was not associated with an increased number of quiescent cells (G0), but led to an accumulation of cells in the G1 phase of the cell cycle. Induced expression of SHIP affects the G1 cell cycle regulators Rb and Kip1. (a) Jurkat vector clone #6 (lanes 1 and 2) and Jurkat SHIP clones #39 (lanes 3 and 4) and #51 (lanes 5 to 9) were incubated for 54 h either without Dox (lanes 1, 3, 5 and 7) or with the indicated concentrations of Dox (lanes 2, 4, 6, 8 and 9 ). Cell lysates were prepared and analyzed by immunoblotting for the expression of SHIP and the retinoblastoma protein (Rb) or for the phosphorylation of Rb on serine residue 780 (phospho-Rb S780). (b) The vector-infected Jurkat clone (vector) or the Jurkat SHIP clone #39 were incubated for 2 days either without (ÀDox) or with 1 mg/ml Dox ( þ Dox). Protein biosynthesis was then blocked by incubating the cells for the indicated times with cycloheximide. Cell extracts were prepared and analyzed for the amounts of Kip1 by immunoblotting (p27 Kip1 ). p24 is a putative proteolytic cleavage product of p27 
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Fluorescent labeling of the cells with CFSE showed that SHIP caused a delay in cell division, but not a complete cell cycle block. Quantification of the transit time through the G1 phase by stathmokinetic analysis revealed that the SHIP-expressing Jurkat cells need 3.5 h longer until 50% of the G1 cells have left the G1 phase of the cell cycle.
A functional role of SHIP in the negative regulation of cell growth has been first demonstrated by Lioubin et al, 43 who described a reduced colony size of FD-Fms cells in soft agar after ectopic expression of SHIP. Additional evidence for an SHIP-mediated regulation of cell growth came from the analysis of SHIP-deficient mice who developed enlarged spleens and lymph nodes and a myeloid hyperplasia. 20, 21 SHIP also plays a crucial role in the FcgRIIB-mediated inhibition of B-cell activation by preventing B cells from entering the cell cycle after the B-cell antigen receptor and the FcgRIIB are crosslinked. 44, 45 Recently, Luo et al 24 reported that expression of SHIP in the cell line K562 established from a patient with chronic myeloid leukemia caused a partial inhibition of cell growth. 24 However, the effect of SHIP on cell growth was not detectable in other hematopoietic cell lines. For example, expression of SHIP in a murine hematopoietic cell line expressing the EPO receptor (DA-ER) did not have an influence on exponentially growing cells, but the SHIP-expressing DA-ER cells showed an increased apoptotic cell death after the cells reached confluence. 46 Similarly, overexpression of SHIP in the human erythropoietin (EPO)-dependent cell line AS-E2 established from a patient with acute myeloid leukemia had no effect on cell growth, but caused increased apoptotic cell death after removal of EPO from the culture medium.
47
Our data clearly indicate that SHIP can have a negative regulatory function on the proliferation of hematopoietic cells and strongly suggest that the level of SHIP expression is critical for both, the biochemical and biological effects of SHIP. The failure of SHIP in mediating a negative regulatory effect on the proliferation of other hematopoietic cell lines described above may be due to a strong positive signaling in these cells which cannot be outweighed by SHIP. Reduction of positive signaling in these cells by suboptimal culture conditions like confluence or factor deprivation may then allow SHIP to mediate an antiproliferative effect. Our data obtained with an inducible expression system are in agreement with such a quantitative model in which the level of SHIP expression is crucial for its negative regulatory effect on cell growth, accumulation in the G1 phase of the cell cycle and reduced phosphorylation of Akt and Rb.
The inducible expression of SHIP in Jurkat cells caused a reduction of the steady-state levels of PtdIns(3,4,5)P 3 and a reduced phosphorylation (Thr-308/Ser-473) and activity of Akt, indicating that SHIP can negatively regulate the PI3K/Akt signaling pathway in these cells. This is in contrast to a recent report by Freeburn et al 48 who observed a reduced phosphorylation of Akt (PKB) without a reduction of the steady-state level of PtdIns(3,4,5)P 3 after the expression of a membrane-localized chimeric CD2:SHIP protein in Jurkat cells. Our data demonstrate that the expression of SHIP in Jurkat cells caused a 69% reduction of the steady-state levels of PtdIns(3,4,5)P 3 which correlated with a 65% reduction of Akt activity. This is of additional interest with respect to recent data suggesting that PtdIns(3,4)P 2 rather than PtdIns(3,4,5)P 3 is the important regulator of Akt activity. [49] [50] [51] It has been described that PtdIns(3,4,5)P 3 inhibits the activity of Akt(PKB) in vitro with a half-maximal inhibitory concentration of 2.5 mM. 51 In the present study, a concentration of 42 52 in human neutrophils after stimulation with FMLP (200 mM). Our data strongly suggest that the activity of Akt is not inhibited by micromolar concentrations of PtdIns(3,4,5)P 3 in vivo. In addition, our data suggest that in Jurkat cells a distinct level of PtdIns(3,4,5)P 3 is essential for phosphorylation of Akt on threonine 308 and serine 473, and that a reduction of PtdIns(3,4,5)P 3 is associated with a reduced phosphorylation and activity of Akt. This is in agreement with recent data from Scheid et al, 53 who observed that PtdIns(3,4,5)P 3 is essential but not sufficient for Akt (PKB) activation.
The SHIP-mediated effect on the downregulation of PI3K/Akt signaling and the inhibition of proliferation of Jurkat cells was not associated with the induction of apoptotic cell death. This was an unexpected result because PI3K/Akt signaling has been implicated in the inhibition of apoptosis by its ability to phosphorylate and inactivate several proapoptotic proteins like Bad, forkhead family transcription factors, IkB kinase and caspase 9.
2,3,54 However, the inhibition of the PI3K/Akt signaling pathway in Jurkat cells by ectopic expression of the tumor suppressor gene PTEN, which removes the 3 0 -phosphate from PtdIns(3,4,5)P 3 , has not always resulted in apoptotic cell death. Wang et al 55 demonstrated that overexpression of PTEN in Jurkat cells, which do not express endogenous PTEN, leads to cell death by apoptosis, but only the high-expressing cells were affected. In another report by Xu et al, 56 overexpression of PTEN in Jurkat cells leads to inhibition of cell growth and renders Jurkat cells more susceptible to apoptotic cell death, but apoptosis without additional apoptotic stimuli has been demonstrated in a small population of cells (about 3%) only. In a third report by Seminario et al, 57 overexpression of PTEN in Jurkat cells leads to reduced proliferation associated with delayed cell cycle progression without any detectable apoptosis. These different results obtained after overexpression of PTEN in Jurkat cells suggest that apoptosis may be observed, only, if the expression level of PTEN reduces the amounts of PI(3,4,5)P 3 under a distinct threshold level. Our data presented in this report show that expression of SHIP in Jurkat cells led to a 69% reduction of PtdIns(3,4,5)P 3 that resulted in a reduced proliferation, but did not cause apoptotic cell death. The remaining amounts of PtdIns(3,4,5)P 3 after expression of SHIP may be sufficient to suppress apoptosis in Jurkat cells. Alternatively, the product generated by SHIP, that is PI(3,4)P 2 , which is not generated by overexpression of PTEN, may play a role in the suppression of apoptosis in SHIP-expressing Jurkat cells. Whether higher levels of SHIP expression can further reduce the level of PtdIns(3,4,5)P 3 and can induce apoptosis in Jurkat cells has to be shown in further experiments.
The observed SHIP-mediated downregulation of proliferation without detectable apoptotic cell death in Jurkat cells is in agreement with the reduced phosphorylation of an Akt substrate associated with proliferation, that is, GSK-3b without affecting the phosphorylation of Akt substrates associated with apoptotic cell death, that is, Bad and FKHR. These results suggest that the observed constitutive phosphorylation of Bad at serine 136 and FKHR at serine 256 in Jurkat cells after reduction of Akt activity may be triggered by another kinase than Akt. A putative candidate may be the p21-activated kinase-1 (PAK1) which can also phosphorylate Bad at serine 136 thereby inhibiting the proapoptotic effect of Bad. 58 An interesting question is how SHIP mediates the observed increase in the transit time of Jurkat cells through the G1 phase of the cell cycle. With respect to the reduced levels of PtdIns(3,4,5)P 3 and reduced activity of Akt after expression of SHIP in Jurkat cells, the PI3K/Akt signaling pathway is a likely candidate. Several models have been described as to how Akt can regulate cell cycle progression. Akt can phosphorylate and inactivate GSK-3b, thereby reducing the GSK-3b-dependent phosphorylation and proteolysis of cyclin D1. 59 In Jurkat cells, a reduced phosphorylation of GSK-3b was observed after expression of SHIP. However, the analysis of the D cyclins in Jurkat cells revealed that cyclin D3, but not cyclin D1, is expressed in Jurkat cells and that in SHIP-expressing Jurkat cells the stability of cyclin D3 is increased, but not decreased, as proposed by the model mentioned above (data not shown). It seems therefore unlikely that the SHIP-mediated reduction of proliferation is associated with a GSK-3b-mediated reduction of D cyclins. In addition, Akt can phosphorylate and inactivate c-Raf-1, thereby downregulating the Raf/MEK/MAPK pathway. 60 In Jurkat cells, SHIP did not affect the constitutive dual phosphorylation of the MAP-kinases Erk1/Erk2 on T202/Y204 in several individual clones (data not shown), even though Akt activity was reduced as described above. Therefore, it seems unlikely that regulation of the MAP-kinases Erk1/2 is involved in the SHIP-mediated antiproliferative effects in Jurkat cells.
Another model as to how Akt can regulate cell cycle progression involves the cyclin-dependent kinase inhibitor p27 Kip1 , which is a negative regulator of CDK activity. Several possibilities have been described as to how Akt can regulate the function of p27 Kip1 . Akt can phosphorylate and inactivate forkhead transcription factors (FKHR, AFX), thereby repressing their potential to activate the transcription of the kip1 gene. 36, 61 In Jurkat cells, the expression of SHIP did not cause an increased transcription of kip1 mRNA (data not shown). Regulation of p27 Kip1 can also occur by post-translational mechanisms like proteolytic processing that eliminates the cyclin-binding domain. 42 Such a proteolytic cleavage of p27 Kip1 was not detectable in Jurkat cells before induction of SHIP and an Nterminally truncated p27
Kip1 was observed in SHIP-expressing Jurkat cells after treatment with cycloheximide only. It is therefore unlikely that reduced proteolytic cleavage of p27 Kip1 is involved in the stabilization of p27
Kip1 in Jurkat cells after the expression of SHIP.
Alternatively, p27 Kip1 is degraded by a ubiquitin-dependent pathway which can be triggered by phosphorylation of p27 Kip1 at Thr-187 by a cyclinE-CDK2 complex. 42, 62 It has been recently shown that Akt can phosphorylate p27
Kip1 at several serine and threonine residues including Ser-10, Thr-157, Thr-187 and Thr-198. 63, 64 Phosphorylation of p27 Kip1 at Thr-187 induces the binding of p27
Kip1 to SKP2 which triggers the ubiquitin-mediated degradation of p27
Kip1 by its association with the SCF ubiquitin-ligase complex. 65 These data suggest a direct function of Akt in the regulation of cell cycle progression by promoting destabilization of p27
Kip1 through direct phosphorylation at Thr-187. 63 In agreement with such a model, the expression of SHIP in Jurkat cells caused a reduced activity of Akt and a stabilization of p27
Kip1 that resulted in an increased steady-state level of p27
Kip1 in Jurkat cells. Whether this stabilization of p27
Kip1 in SHIP-expressing Jurkat cells is due to a reduced phosphorylation of p27 Kip1 at Thr187 leading to a reduced proteasome-dependent degradation of p27 Kip1 has to be analyzed in further experiments.
According to current models of cell cycle regulation, the phosphorylation of the Rb protein by cyclin-dependent kinases is an important step for the transition from G1 to S phase. 38, 66 It has been shown that Rb phosphorylated at Ser-780 cannot bind to the transcription factor E2F anymore, thereby releasing E2F from Rb and inducing the transcription of genes necessary for G1/S transition. 40 In agreement with this model, a reduction of the phosphorylation of Rb at Ser-780 and an increase in the number of G1 cells was observed after expression of SHIP in Jurkat cells. In summary, these data implicate Kip1 and Rb as targets in the SHIP-mediated increase of the transit time through the G1 phase of the cell cycle.
What could be the biological consequence of these results? Our data indicate that the restoration of SHIP expression in leukemia cells, which have lost expression of endogenous SHIP, can downregulate the proliferation of these cells by increasing the transit time through the G1 phase of the cell cycle. These observations offer the possibility that a loss of SHIP expression may cause an increased proliferation of hematopoietic cells by shortening the G1 phase. Such an SHIP-mediated effect on the proliferation of hematopoietic cells may contribute to the development of a hyperplasia as observed in the SHIP knockout mice. 20, 21 PI3K/Akt signaling and the cell cycle regulators Kip1 and Rb may be crucial in mediating this proliferative effect of SHIP. The recent identification of a mutation in the phosphatase domain of SHIP in the primary cells of a patient with acute myeloid leukemia suggests that mutations that reduce SHIP activity can occur during the leukemogenic process in vivo.
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Further experiments are necessary to measure the expression and activity of SHIP in primary cells from leukemia patients and in normal hematopoietic cells in more detail.
